Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;105(8):131-6.
doi: 10.3238/arztebl.2008.0131. Epub 2008 Feb 22.

Benefit and risk of mammography screening: considerations from an epidemiological viewpoint

Affiliations

Benefit and risk of mammography screening: considerations from an epidemiological viewpoint

Nikolaus Becker et al. Dtsch Arztebl Int. 2008 Feb.

Abstract

Introduction: An organized mammography screening program is being implemented in Germany since the end of 2005. Even before its inception, a heated debate surrounded the question of how to communicate its rationale appropriately.

Methods: Selective literature review identifying facts relevant to informing decision making about mammography attendance.

Results: Decision making about individual attendance for mammography screening is crucially dependent on the reduction of risk of death from breast cancer for a diseased woman. This can be communicated in the following way: out of 100 women with a diagnosis of breast cancer 31 will die within the following 10 years without screening and 20 with screening (35% fewer).

Discussion: The actuarial concept of risk is defined by the probability of the undesired event multiplied by the expected magnitude of loss. This approach appears more appropriate for the appraisal of risk in the context of mammography screening than a pure event probability. It could help understand why women attend screening even if they perceive the risk of getting breast cancer as low--namely, that they rank the consequences of getting the disease as highly significant for themselves and others in their social environment.

Keywords: breast cancer; early detection; epidemiology; quality assurance; randomized studies; screening; survival time.

PubMed Disclaimer

Comment in

  • Overestimation of reduction in mortality.
    Weymayr C. Weymayr C. Dtsch Arztebl Int. 2008 Jun;105(23):419; author reply 421-2. doi: 10.3238/arztebl.2008.0419b. Epub 2008 Jun 6. Dtsch Arztebl Int. 2008. PMID: 19626165 Free PMC article. No abstract available.
  • Inaccurate estimation of everyday risks.
    Beise R. Beise R. Dtsch Arztebl Int. 2008 Jun;105(23):419; author reply 421-2. doi: 10.3238/arztebl.2008.0419a. Epub 2008 Jun 6. Dtsch Arztebl Int. 2008. PMID: 19626166 Free PMC article. No abstract available.
  • Judgement and decision processes.
    Klemperer D. Klemperer D. Dtsch Arztebl Int. 2008 Jun;105(23):419-20; author reply 421-2. doi: 10.3238/arztebl.2008.0420a. Epub 2008 Jun 6. Dtsch Arztebl Int. 2008. PMID: 19626167 Free PMC article. No abstract available.
  • Discussing the benefit-harm debate.
    Jöckel KH, Hoffmann B, Stang A. Jöckel KH, et al. Dtsch Arztebl Int. 2008 Jun;105(23):420-1; author reply 421-2. doi: 10.3238/arztebl.2008.0421a. Epub 2008 Jun 6. Dtsch Arztebl Int. 2008. PMID: 19626168 Free PMC article. No abstract available.
  • Shared decision-making.
    Abholz HH. Abholz HH. Dtsch Arztebl Int. 2008 Jun;105(23):420; author reply 421-2. doi: 10.3238/arztebl.2008.0420b. Epub 2008 Jun 6. Dtsch Arztebl Int. 2008. PMID: 19626169 Free PMC article. No abstract available.
  • Stage-dependent lethality.
    Schwartz WF. Schwartz WF. Dtsch Arztebl Int. 2008 Jun;105(23):421; author reply 421-2. doi: 10.3238/arztebl.2008.0421b. Epub 2008 Jun 6. Dtsch Arztebl Int. 2008. PMID: 19626170 Free PMC article. No abstract available.
  • Randomized controlled trials are needed.
    Mühlhauser I. Mühlhauser I. Dtsch Arztebl Int. 2008 Jun;105(23):421; author reply 421-2. doi: 10.3238/arztebl.2008.0421c. Epub 2008 Jun 6. Dtsch Arztebl Int. 2008. PMID: 19626171 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Mühlhauser I, Höldke B. Information zum Mammographiescreening - vom Trugschluss zur Ent-Täuschung. Radiologe. 2002;42:299–304. - PubMed
    1. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ. 2003;327:741–744. - PMC - PubMed
    1. Morrison AS. Monographs in Epidemiology and Biostatistics. Second edition. Volume 19. New York, Oxford: Oxford University Press; 1992. Screening in Chronic Disease.
    1. Becker N. Screening aus epidemiologischer Sicht. Radiologe. 2002;42:592–600. - PubMed
    1. Becker N. Die Rolle der epidemiologischen Qualitätsparameter im Mammographie-Screening. Radiologie. 2006;46:984–992. - PubMed